During the reinspection, the production conditions at the Company’s 11 sites manufacturing sterile and non-sterile medicinal products, including four new production sites, were audited.
Farmak JSC is expecting the inspection report within the term established by the Croatian laws.
The positive result of the reinspection will facilitate Farmak’s expansion to the European markets.
According to the notice of the State Service of Ukraine on Medicines and Drug Control, “The passing of such procedure and the extension of the GMP certificate validity for Farmak, a Ukrainian manufacturer, is a confirmation of the quality of medicinal products manufactured by the Company, as well as their marketing authorizations”.
Previous inspections by HALMED, the Croatian regulatory agency, were conducted at Farmak JSC in 2015. Following the inspections, the Company obtained the corresponding GMP certificates.
The TOP 100 of the country’s most valued trademarks was presented by Novoe Vremya magazine in association with MPP Consulting. The cost of each brand was estimated by MPP Consulting. The valuation methodology is based on financial performance of brand owners, as well as factors that may influence the brand’s value, such as geographical coverage [&helli...
This edition is dedicated to Quality in all its manifestations and areas. In this edition, we discuss the following issues: How to protect oneself from drug falsification; • Where can one read about drug bioequivalence; • How are drugs disposed of; • How Farmak cares about the quality of its drugs. We remind that ‘Farmak […]
The purpose of the visit was to increase sustainability in the healthcare sector. On 15 November, Farmak welcomed the representatives of the government, non-governmental organizations, research institutes and UN system agencies within the framework of the Sustainable Procurement Workshop of the United Nations Development Programme. During the visit, the gues...